首页> 外文OA文献 >Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT

【2h】

Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT

机译：对骨腐蚀进展的抑制作用对类木质瘤性关节炎患者骨腐蚀进展的对比研究：HR-PQCT的开放式随机对照试验研究方案

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Naoki Iwamoto; Shuntaro Sato; Remi Sumiyoshi; Ko Chiba; Nanami Miyamoto; Kumiko Arinaga; Makiko Kobayashi; Hiroshi Yamamoto; Makoto Osaki; Atsushi Kawakami;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类
入库时间 2022-08-20 22:12:41

相似文献

外文文献
中文文献
专利

1. Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT [J] . Naoki Iwamoto, Shuntaro Sato, Remi Sumiyoshi, Trials . 2019,第1期

机译：风湿性关节炎患者中使用地诺单抗和常规治疗对骨侵蚀进展的抑制作用的比较研究：HR-pQCT的开放标签随机对照试验的研究方案
2. Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial [J] . Takeuchi Tsutomu, Tanaka Yoshiya, Ishiguro Naoki, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2016,第6期

机译：地诺单抗对日本类风湿性关节炎患者的影响：甲氨蝶呤风湿性关节炎患者中AMG 162（Denosumab）的剂量反应研究，以验证其对骨侵蚀（DRIVE）的抑制作用-12个月，多中心，随机，双盲目，安慰剂对照，II期临床试验
3. Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study [J] . Takeshi Mochizuki, Koichiro Yano, Katsunori Ikari, Osteoporosis and Sarcopenia . 2021,第3期

机译：romoSozumab或Denosumab治疗对具有严重骨质疏松症的类风湿性关节炎患者骨矿物密度和疾病活性的影响：开放标签，随机，试点研究
4. Antiresorptive effect of denosumab in the treatment of osteoporosis in patients with rheumatoid arthritis [C] . M. A. Korolev, N. E. Banshchikova, E. A. Letjagina, 2017 International Multi-Conference on Engineering, Computer and Information Sciences . 2017

机译：地诺单抗对类风湿关节炎骨质疏松症的抗吸收作用
5. Efficacy of the Chinese herbal formula CUF2 in the treatment of childhood asthma: Animal experiment, in vitro study and randomized, double-blinded, placebo-controlled clinical trial. [D] . Wong, Yeuk Oi. 2006

机译：中药配方CUF2在治疗儿童哮喘中的功效：动物实验，体外研究以及随机，双盲，安慰剂对照的临床试验。
6. Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT [O] . Naoki Iwamoto, Shuntaro Sato, Remi Sumiyoshi, 2019

机译：风湿性关节炎患者中地诺单抗和常规治疗对骨侵蚀进展的抑制作用比较研究：HR-pQCT的开放标签随机对照试验的研究方案
7. Faculty Opinions recommendation of Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial. [O] . Sakae Tanaka 2019

机译：教师意见Denosumab对日本类风湿性关节炎患者的建议：AMG 162（Denosumab）对类风湿性关节炎患者对甲氨蝶呤抑制骨侵蚀（驱动）-A的抑制作用（驱动）-A 12个月，Multicentre的抑制作用的剂量 - 反应研究。随机，双盲，安慰剂控制，II期临床试验。

Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT

著录项

相似文献

相关主题

期刊订阅